Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice.
Aberrant tissue repair and persistent inflammation following oxidant-mediated acute lung injury (ALI) can lead to the development and progression of various pulmonary diseases, but the mechanisms underlying these processes remain unclear. Hyperoxia is widely used in the treatment of pulmonary diseases, but the effects of this oxidant exposure in patients undergoing recovery from ALI are not clearly understood. Nrf2 has emerged as a crucial transcription factor that regulates oxidant stress through the induction of several detoxifying enzymes and other proteins. Using an experimental model of hyperoxia-induced ALI, we have examined the role of oxidant stress in resolving lung injury and inflammation. We found that when exposed to sublethal (72 h) hyperoxia, Nrf2-deficient, but not wild-type mice, succumbed to death during recovery. When both genotypes were exposed to a shorter period of hyperoxia-induced ALI (48 h), the lungs of Nrf2-deficient mice during recovery exhibited persistent cellular injury, impaired alveolar and endothelial cell regeneration, and persistent cellular infiltration by macrophages and lymphocytes. Glutathione (GSH) supplementation in Nrf2-deficient mice immediately after hyperoxia remarkably restored their ability to recover from hyperoxia-induced damage in a manner similar to that of wild-type mice. Thus, the results of the present study indicate that the Nrf2-regulated transcriptional response and, particularly GSH synthesis, is critical for lung tissue repair and the resolution of inflammation in vivo and suggests that a dysfunctional Nrf2-GSH pathway may compromise these processes in vivo.
Reddy
Narsa M
NM
Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Kleeberger
Steven R
SR
Kensler
Thomas W
TW
Yamamoto
Masayuki
M
Hassoun
Paul M
PM
Reddy
Sekhar P
SP
D055371:Acute Lung Injury / Q000209:etiology*; D000818:Animals; D005978:Glutathione / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use; D018496:Hyperoxia / Q000150:complications* / Q000473:pathology; D007249:Inflammation / Q000209:etiology*; D008168:Lung / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D018345:Mice, Knockout; D051267:NF-E2-Related Factor 2 / Q000172:deficiency* / Q000502:physiology; D018384:Oxidative Stress; D012038:Regeneration; D014157:Transcription Factors; D014158:Transcription, Genetic
D051267:NF-E2-Related Factor 2; D014157:Transcription Factors; D005978:Glutathione